Improving inhaled antibiotic treatment - Practice defeats the proof.


Important improvements in the prognosis of patients with cystic fibrosis (CF) have been realized by a more timely and aggressive treatment of pulmonary infections [1]. This approach has been built on understanding the biology, epidemiology and clinical outcomes of the complex lung microbiology and host response in this group of patients [2,3]. Although new… (More)
DOI: 10.1016/j.jcf.2016.10.003


  • Presentations referencing similar topics